1. Home
  2. LULU vs ILMN Comparison

LULU vs ILMN Comparison

Compare LULU & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo lululemon athletica inc.

LULU

lululemon athletica inc.

HOLD

Current Price

$173.43

Market Cap

19.9B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$129.34

Market Cap

20.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LULU
ILMN
Founded
1998
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Apparel
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.9B
20.4B
IPO Year
2007
2000

Fundamental Metrics

Financial Performance
Metric
LULU
ILMN
Price
$173.43
$129.34
Analyst Decision
Hold
Hold
Analyst Count
25
17
Target Price
$212.97
$124.24
AVG Volume (30 Days)
1.9M
2.3M
Earning Date
03-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
20.00
170.87
EPS
8.29
5.45
Revenue
$10,588,126,000.00
$4,343,000,000.00
Revenue This Year
$6.59
$6.52
Revenue Next Year
$4.40
$5.49
P/E Ratio
$21.05
$23.84
Revenue Growth
10.07
N/A
52 Week Low
$159.25
$68.70
52 Week High
$363.88
$155.53

Technical Indicators

Market Signals
Indicator
LULU
ILMN
Relative Strength Index (RSI) 42.13 51.27
Support Level $160.62 $124.27
Resistance Level $184.31 $132.15
Average True Range (ATR) 6.32 4.28
MACD 0.21 1.86
Stochastic Oscillator 21.33 76.83

Price Performance

Historical Comparison
LULU
ILMN

About LULU lululemon athletica inc.

Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 780 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 40 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: